The Public Health Response to Blood Disorders

American Journal of Preventive Medicine

Volumn 38, Issue 4 SUPPL., 2010, Pages

  Atrash, Hani K ^a   Parker, Christopher S ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ARTICLE; AWARENESS; BLOOD DISEASE; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DEMOGRAPHY; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; EVIDENCE BASED PRACTICE; HEALTH CARE SYSTEM; HEALTH EDUCATION; HUMAN; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PREVENTIVE MEDICINE; PROGRAM DEVELOPMENT; PUBLIC HEALTH SERVICE;

EID: 77949506710     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2010.01.006     Document Type: Note

References (32)

1. Silverstein M.D., Heit J.A., Mohr D.N., et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158 6 (1998) 585-593
2. Looker A.C., Dallman P.R., Carroll M.D., Gunter E.W., and Johnson C.L. Prevalence of iron deficiency in the U.S. JAMA 277 12 (1997) 973-976
3. Da Costa L., Willig T.N., Fixler J., et al. Diamond-Blackfan anemia. Curr Opin Pediatr 13 1 (2001) 10-15
4. Ashley-Koch A., Yang Q., and Olney R.S. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. Am J Epidemiol 151 (2000) 839-845
5. Sickle Cell Disease Guideline Panel. Sickle cell disease: screening, diagnosis, management, and counseling in newborns and infants. Clinical Practice Guideline No. 6 (1993), Agency for Healthcare Policy and Research, USDHHS, Rockville MD (AHCPR publication 93-0562)
6. Edwards C.Q., Griffen L.M., Goldgar D., Drummond C., Skolnick M.H., and Kushner J.P. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 318 (1988) 1355-1362
7. Guttmacher A.E., Marchuck D., and Pyeritz R.E. Hereditary hemorrhagic telangiectasia. In: Rimoin D.L., Conner J.M., Pyeritz R.E., and Korf B.R. (Eds). Principles and practice of medical genetics. 5 ed. (2007), Churchill Livingstone, Philadelphia 1200-1213
8. Weinberg E.D. Iron out of balance: a risk factor for acute and chronic diseases. Hemoglobin 32 1-2 (2008) 117-122
9. USDHHS. Healthy People 2010. With Understanding and Improving Health and Objectives for Improving Health. 2nd ed. 2 vols (2000), U.S. Government Printing Office, Washington
10. Soucie J.M., Evatt B., and Jackson D.t.H.S.S.P.Investigators. Occurrence of hemophilia in the U.S. Am J Hematology 59 (1988) 288-294
11. Hassell K.L. Population estimates of sickle cell disease in the U.S. Am J Prev Med 38 4S (2010) S512-S521
12. Anderson Jr. F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151 5 (1991) 933-938
13. Kung H.C., Hoyert D.L., Xu J.Q., and Murphy S.L. Deaths: final data for 2005. National vital statistics reports; vol 56, no 10 (2008), National Center for Health Statistics, Hyattsville MD
14. Schulman S., Lindmarker P., Holmstrom M., et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 4 4 (2006) 734-742
15. Mohr D.N., Silverstein M.D., Heit J.A., Petterson T.M., O'Fallon W.M., and Melton L.J. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc 75 12 (2000) 1249-1256
16. Prandoni P., Bernardi E., Marchiori A., et al. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ 329 7464 (2004) 484-485
17. Kahn S.R., Kearon C., Julian J.A., et al. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost 3 4 (2005) 718-723
18. National Coordinating and Evaluation Center. Sickle Cell Disease and Newborn Screening Program. www.sicklecelldisease.net/
19. American Public Health Association. Annual Report 2009. http://www.aphaportal.org/APHA%202009%20anreport%20WEB.pdf
20. American Public Health Association. 2008 Annual Meeting abstract search. apha.confex.com/apha/136am/webprogram/start.html
21. U.S. Census Bureau News. An older and more diverse nation by midcentury. CB08-123 (2008), U.S. Department of Commerce, Washington DC
22. USDHHS. The Surgeon General's call to action to prevent and decrease overweight and obesity (2001), USDHHS, Public Health Service, Office of the Surgeon General, Rockville MD
23. USDHHS. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism (2008), USDHHS, Public Health Service, Office of the Surgeon General, Rockville MD
24. Meyer-Michel S. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. Arch Intern Med 160 (2000) 3415-3420
25. Soucie M.J., Gianfrini C., Janco R.L., et al. Joint range of motion limitations among young males with hemophilia: prevalence and risk factors. Blood 103 (2004) 2467-2473
26. Prescott R.J., Jones D.R., Vasilescu C., Henderson J.T., and Ruckley C.V. Smoking and risk factors in deep vein thrombosis. J Thromb Haemost 40 1 (1978) 128-133
27. Moore J., House P., Wood R., and Mertz E. The Public Health Workforce: a six state case study. Abstract 1564, AcademyHealth meeting (2004) San Diego CA
28. Fung E.B., Harmartz P.R., Milet M., et al. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who receive transfusions. Transfusion 49 9 (2008) 1971-1980
29. Bezemer I.D., van der Meer X., Eikenboom J., Rosendaal J.F.R., and Doggen C. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 169 6 (2009) 610-615
30. Smith F.B., Lee A.J., Fowkes F., Price J.F., Rumley A., and Lowe G. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 17 (1997) 3321-3325
31. IOM. The future of public health (1988), National Academy Press, Washington
32. CDC. National Public Health Performance Standards Program: ten essential public health services. www.cdc.gov/od/ocphp/nphpsp/essentialphservices.htm